Metabolic Disorders
Test your knowledge of pediatric obesity classification, causes, and clinical guidelines with this interactive quiz.
Dr. Cho Han Chiang reviews GI risks of GLP-1 RAs, balancing safety with their metabolic and cardiovascular benefits.
Once-daily oral therapy shows strong efficacy in obesity, with regulatory submission expected by the end of 2025.
Study finds mitochondrial protein misfolding drives beta cell failure in T2D, making LONP1 a potential therapy target.
Dr. Angelo Avogaro explains how incretin hormones support cardiovascular and metabolic health in type 2 diabetes treatment.
Tirzepatide shows front-line potential in type 2 diabetes with heart disease, per Lilly’s SURPASS-CVOT outcomes trial.
Dr. Neil Iyengar discusses how metabolic dysfunction impacts cancer risk, progression, and response to treatment.
Emerging therapies targeting metabolism may improve cancer care and survivorship, Dr. Neil Iyengar explains.
How much do you know about obesity? Test your clinical IQ with this quick quiz for healthcare professionals.
Tirzepatide improved testosterone, body composition, sexual function in men with obesity-related hypogonadism, study finds.
Over half of T2DM patients in primary care have MASLD; over 10% of those with obesity may have advanced fibrosis.
Semaglutide improves liver health in MASH via weight loss and proteomic pathways, per a new Nature Medicine study.
Once-weekly semaglutide improved weight, insulin needs, and glycemic control in adults with T1D and obesity.
Amycretin shows significant weight loss and tolerability in early trial, supporting further study for obesity treatment.
ADA’s new clinical guidelines aim to eliminate weight stigma and bias in obesity care across US healthcare settings.
Evidence-based tips on GLP-1s, nutrition, exercise, and mindset to support sustainable weight loss and better health.
Personalized obesity care combining medication and lifestyle delivers better, longer-lasting weight loss and health outcomes.
When diet and exercise wave the white flag, real medicine rolls in like the superhero with a prescription pad!
Dr. Alex McDonald and Dr. Regina Ragasa explore obesity’s health impact and a multifaceted approach for effective care.
Orforglipron, a daily oral GLP-1 pill, matches Ozempic in Phase 3 trial, offering a needle-free option for Type 2 diabetes.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.